CMS Increases Medicare Payments for COVID-19

Today, April 15, 2020, CMS announced that Medicare payments for certain laboratory tests that use high-throughput (more than 200 specimens per day) technologies to "rapidly diagnose large numbers of 2019 Novel Coronavirus (COVID-19) cases" will be increased to $100, effective April 14, 2020, through the duration of the COVID-19 emergency.

View CMS's April 15, 2020, press release announcing the increased payments rates.

View the complete guidance.

NILA News

5/24/2024
FDA Publishes Proposed Enforcement Policies for Tests During a Declared Emergency

5/6/2024
Final Rule on LDTs officially published in Federal Register

4/29/2024
NILA and American Association of Bioanalysts (AAB) Respond to FDA's Release of Final Rule on LDTs

Laboratory Outreach Communications System (LOCS)

Click here for laboratory-related information and communications from the Centers for Disease Control and Prevention (CDC).